{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:53:14Z","timestamp":1761101594788},"reference-count":30,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":602,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Genetics"],"published-print":{"date-parts":[[2000,5]]},"abstract":"<jats:p>The perceived benefits and risks of genetic testing may vary between groups of individuals with different cultural, demographic, and family history features. This multicentre study examined the factors that influenced the decision to undergo genetic testing for BRCA1 and BRCA2 in Canadian Jewish women with breast cancer. A self\u2010administered questionnaire was developed and distributed to 134 individuals enrolled in a research\u2010based testing program for Ashkenazi women. The questionnaire assessed demographic, social, and family history parameters, and the influence of medical, family, social, psychological, and cultural\/religious factors on decision making about genetic testing. Seventy\u2010six percent of women completed the questionnaire. Forty\u2010one percent of study participants had no family history of breast or ovarian cancer. The most important factors influencing the decision to undergo testing were a desire to contribute to research, potential benefit to other family members, curiosity, and the potential for relief if not found to be a carrier (endorsed by 87, 78, 70, and 60% of participants, respectively). The main perceived risks of undergoing genetic testing related to insurance discrimination, confidentiality, accuracy and interpretability of results, potential impact on marriage prospects for family members, and focus on the Jewish community (endorsed by 28, 24, 30, 17, and 14% of participants, respectively). This study provides novel information on the motivating factors for BRCA1 and BRCA2 mutation testing in Canadian women of Ashkenazi Jewish descent. The focus on altruistic factors and those related to perceived psychological benefits of testing is notable.<\/jats:p>","DOI":"10.1034\/j.1399-0004.2000.570508.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T11:23:18Z","timestamp":1047381798000},"page":"376-383","source":"Crossref","is-referenced-by-count":35,"title":["Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2"],"prefix":"10.1111","volume":"57","author":[{"given":"Kelly\u2010Anne","family":"Phillips","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy S","family":"Meschino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abdolell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Glendon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene L","family":"Andrulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela J","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7545954"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/378789a0"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.1997.03540360065034","article-title":"Recommendations for follow\u2010up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2","volume":"277","author":"Burke W","year":"1997","journal-title":"J Am Med Assoc"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1037\/0278-6133.16.1.63","article-title":"Psychological responses to BRCA1 mutation testing: preliminary findings","volume":"16","author":"Croyle RT","year":"1997","journal-title":"Health Psych"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2063::AID-CNCR1>3.0.CO;2-Q"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605023341812"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5287.621"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.1996.03530480027036","article-title":"BRCA1 testing in families with hereditary breast\u2010ovarian cancer: a prospective study of patient decision making and outcomes","volume":"275","author":"Lerman C","year":"1996","journal-title":"J Am Med Assoc"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.1997.6.317"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/jama.1997.03540420063031","article-title":"Genetic testing for susceptibility to adult\u2010onset cancer: the process and content of informed consent","volume":"277","author":"Geller G","year":"1997","journal-title":"J Am Med Assoc"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2219::AID-CNCR21>3.0.CO;2-Y"},{"key":"e_1_2_6_13_2","first-page":"169","article-title":"Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families","volume":"4","author":"Streuwing JP","year":"1995","journal-title":"Cancer Epi Bio Prev"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.4.843"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530480027036"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.2.148"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-3991(97)00064-5"},{"key":"e_1_2_6_18_2","first-page":"361","article-title":"Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing","volume":"4","author":"Lerman C","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_6_19_2","first-page":"369","article-title":"Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington","volume":"4","author":"Durfy SJ","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_6_20_2","first-page":"329","article-title":"Correlates of intentions to obtain genetic counselling and colorectal cancer gene testing among at\u2010risk relatives from three ethnic groups","volume":"8","author":"Glanz K","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_6_21_2","unstructured":"Breast Cancer Information core [BIC] database on the World Wide Web athttp:\/\/www.nhgri.nih.gov\/Intramural_research\/Lab_transfer\/Bic\/"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1095-198"},{"key":"e_1_2_6_23_2","first-page":"189","article-title":"BRCA1 mutations in Ashkenazi Jewish women","volume":"57","author":"Tonin P","year":"1995","journal-title":"Am J Hum Genet"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1096-188"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1096-185"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.2.494"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.14.1241"},{"key":"e_1_2_6_28_2","first-page":"135","article-title":"How are Jewish women different from all other women?","volume":"7","author":"Press N","year":"1997","journal-title":"Health Matrix"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1295-364"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320470214"},{"key":"e_1_2_6_31_2","first-page":"793","article-title":"Twenty\u2010year outcome analysis of genetic screening programs for Tay\u2013Sachs and \u03b2\u2010thalassemia disease carriers in high schools","volume":"59","author":"Mitchell JJ","year":"1996","journal-title":"Am J Hum Genet"}],"container-title":["Clinical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-0004.2000.570508.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-0004.2000.570508.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-0004.2000.570508.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T11:53:58Z","timestamp":1698580438000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-0004.2000.570508.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["10.1034\/j.1399-0004.2000.570508.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-0004.2000.570508.x","archive":["Portico"],"relation":{},"ISSN":["0009-9163","1399-0004"],"issn-type":[{"value":"0009-9163","type":"print"},{"value":"1399-0004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}